1. Home
  2. XYLO

as 05-20-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

Founded: 1999 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 3.6M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 15.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -9.45 EPS Growth: N/A
52 Week Low/High: $1.50 - $6.91 Next Earning Date: 05-28-2024
Revenue: $91,724,000 Revenue Growth: 806.54%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks:

Latest XYLO TECHNOLOGIES LTD SPON ADS EACH REP 15 ORD SHS (POST SPLT) News

XYLO Breaking Stock News: Dive into XYLO Ticker-Specific Updates for Smart Investing

All XYLO News